Sun Pharma

Reportedly, updated cost analysis reveals ILUMYA is among the most cost-effective first-line treatments for moderate-to-severe…

Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the…

AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects…

Nafamostat is identified as a potential candidate for COVID-19 patients by scientists at the University of Tokyo and Leibniz…

It is a potential treatment for atopic dermatitis, psoriasis and other auto-immune disorders

The slump in profits was largely attributed to the Rs 260 crore settlement charges paid by the company to the Department of…

The state government has decided to seal the factory on Monday and quarantine all employees

Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD)…

Rahul Agarwal, Director, Wealth Discovery, explains how the once beaten-down sector, has recently witnessed sharp uptick with…

US FDA classifies Sun Pharma's Halol facility as official action indicated